Meningococcal Vaccination

Your questions answered

Translate to Spanish or other 102 languages!

Teens and young adults are at increased risk for meningococcal disease. Meningococcal disease is a very serious illness where death can occur in as little as a few hours. Talk with a doctor about meningococcal vaccination to help protect your child’s health. Image for illustration purposes
Teens and young adults are at increased risk for meningococcal disease. Meningococcal disease is a very serious illness where death can occur in as little as a few hours. Talk with a doctor about meningococcal vaccination to help protect your child’s health. Image for illustration purposes

Mega Doctor News

- Advertisement -

Teens and young adults are at increased risk for meningococcal disease. Meningococcal disease is a very serious illness where death can occur in as little as a few hours. Talk with a doctor about meningococcal vaccination to help protect your child’s health.

There are two types of meningococcal vaccines licensed in the United States:

  • Meningococcal conjugate (MenACWY) vaccines
  • Serogroup B meningococcal (MenB) vaccines

These vaccines help prevent the most common causes of meningococcal disease in the United States.

- Advertisement -

CDC recommends meningococcal vaccines for preteens, teens, and certain other people

CDC recommends MenACWY vaccine for:

  • All preteens at 11 to 12 years old
  • All teens at 16 years old

The booster dose at 16 years old gives teens continued protection during the ages when they are at highest risk.

Teens and young adults (16 through 23 year olds) may also get MenB vaccine.

  • Preferred age is 16 through 18 years old
  • Multiple doses needed for best protection
  • Must get the same brand for all doses

Younger children and adults usually do not need meningococcal vaccines. However, CDC recommends one or both types of meningococcal vaccines for people with

- Advertisement -
  • Certain medical conditions
  • Travel plans to areas where the disease is common
  • Jobs working with the bacteria
  • Increased risk due to a meningococcal disease outbreak

Meningococcal vaccines are safe but side effects can occur

About half of people who get a MenACWY vaccine have mild problems following vaccination:

  • Redness or pain where they got the shot
  • Fever

These reactions usually get better on their own within 1 to 2 days, but serious reactions are possible.

Following MenB vaccination, more than half of people who get the vaccine will have mild problems:

  • Soreness, redness, or swelling where they got the shot
  • Fatigue (tiredness)
  • Headache
  • Muscle or joint pain
  • Fever or chills
  • Nausea or diarrhea

These reactions usually get better on their own within 3 to 7 days, but serious reactions are possible.

Information source: CDC

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Common Misconceptions When Treating Fevers

Whether you have a fever or your little one does, it can be easy to assume you need to treat it with medication.

$281 Million Unlocked to Bridge the Gap in Rural Medical Access

AUSTIN - Governor Greg Abbott announced the Texas Health and Human Services Commission (HHSC) will receive $281 million in federal funding for the second year of Rural Texas Strong, a five-year initiative to improve rural healthcare throughout the state.

Skin Myths Dermatologists Want You to Stop Believing Immediately

Have you ever wondered what a dermatologist's top skincare recommendations are

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk 

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.” 
- Advertisement -